Merit Medical Systems Profit Margin 2006-2019 | MMSI

Current and historical gross margin, operating margin and net profit margin for Merit Medical Systems (MMSI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Merit Medical Systems net profit margin as of March 31, 2019 is 4.68%.
Merit Medical Systems Annual Profit Margins
Merit Medical Systems Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $3.019B $0.883B
Merit Medical Systems, Inc. set out to build the world's most customer-focused healthcare company by understanding customers' needs, and innovating and delivering a diverse range of products that improve the lives of people, families, and communities throughout the world. Merit's primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $61.596B 20.52
Align Technology (ALGN) United States $25.810B 69.68
McKesson (MCK) United States $23.745B 9.20
AmerisourceBergen (ABC) United States $16.337B 11.60
Laboratory Of America Holdings (LH) United States $16.194B 15.14
Cooper (COO) United States $14.453B 25.21
Cardinal Health (CAH) United States $13.422B 8.69
DENTSPLY SIRONA (XRAY) United States $12.735B 26.55
Henry Schein (HSIC) United States $10.125B 17.02
West Pharmaceutical Services (WST) United States $8.554B 39.73
CONMED (CNMD) United States $2.268B 36.18
Patterson (PDCO) United States $2.098B 16.58
Atrion (ATRI) United States $1.638B 46.78
STAAR Surgical (STAA) United States $1.069B 72.85
Antares Pharma (ATRS) United States $0.457B 0.00
Invacare (IVC) United States $0.226B 0.00
Lifevantage (LFVN) United States $0.164B 21.70
Endologix (ELGX) United States $0.117B 0.00
Pro-Dex (PDEX) United States $0.057B 17.64
Biolase (BIOL) United States $0.040B 0.00